A STUDY ON PATTERN OF PRESCRIBING MEDICATIONS USED IN SECONDARY PREVENTION OF STROKE
DOI:
https://doi.org/10.22159/ajpcr.2016.v9s3.14071Abstract
ABSTRACT
Objectives: The main objectives of this study were to estimate the demographic details of patients with the first incidence of stroke and to study the
various risk factors for ischemic stroke.
Methods: It was a retrospective, observational study carried out for 1 year at the Department of Stroke Medicine of a tertiary care teaching hospital
in Kerala, India. A total of 636 patients were admitted under stroke medicine during the period from July 1, 2014, to July 1, 2015, and who satisfied
the inclusion and exclusion criteria were included in the study. A standardized data collection form was prepared and necessary data were collected
from patient's medical records.
Results: The maximum number of patients was in the age group of 60-69 years. 65.1% patients were residing in the rural area. 60.7% patients were
male. Most of them had hypertension as common comorbidity (21.35%) and the highest number of patients had diabetes mellitus and hypertension
(21.7%). Majority of the patients were prescribed with antiplatelets (94.91%), followed by statins (93.8%).
Conclusion: A strict control on the comorbid conditions and sticking on to the medications can prevent the occurrence of future stroke.
Keywords: Stroke, Secondary prevention, Drugs, Prescribing pattern.
Downloads
References
National Collaborating Centre for Chronic Conditions. Stroke: National Clinical Guideline for Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA). 3rd ed. London: Royal College of Physicians; 2008.
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(7):2064-89.
Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 2010;17(3):197-218.
Johnston SC. Clinical practice. Transient ischemic attack. N Engl J Med 2002;347(21):1687-92.
Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack – Proposal for a new definition. N Engl J Med 2002;347(21):1713-6.
Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy a Pathophysiologic Approach. 8th ed. New York: McGraw-Hill Medical; 2008.
Lakshmi R, James E, Kirthivasan R. Study on impact of clinical pharmacist’s interventions in the optimal use of oral anticoagulants in stroke patients. Indian J Pharm Sci 2013;75(1):53-9.
Bhattacharya S, Saha SP, Basu A, Das SK. A 5 years prospective study of incidence, morbidity and mortality profile of stroke in a rural community of eastern India. J Indian Med Assoc 2005;103(12):655-9.
Sethi PK. Stroke-incidence in India and management of ischaemic stroke. Neuroscience 2002;4(3):139-41.
Belcastro V, Costa C, Galletti F, Autuori A, Pierguidi L, Pisani F, et al. Levetiracetam in newly diagnosed late-onset post-stroke seizures: A prospective observational study. Epilepsy Res 2008;82(2-3):223-6.
Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994;25(2):333-7.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
